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a proapoptotic  function  in  the DNA 
damage  response, and  these  func-
tions may be independent. We pro-
pose  that  in  response  to  low  levels 
of  DNA  damage,  the  ATM-depen-
dent  prosurvival  function  springs 
into action. If this function is defec-
tive,  DNA  damage  will  accumulate 
activating  a  cell  death  pathway 
that may not involve a proapoptotic 
function of Bid. On the other hand, 
high  levels  of  DNA  damage  could 
lead  to  activation  of  the  proapop-
totic  function  of  Bid  in  mitochon-
dria.  In  the  case  of  hematopoietic 
cells,  low  levels  of  DNA  damage 
may lead to “death by default” such 
that a deficiency in Bid (prosurvival 
function)  results  in  hypersensitiv-
ity  (as  reported by Zinkel  et  al.).  In 
the case of fibroblasts and neurons, 
relatively  high  levels  of  DNA  dam-
age may be  required  to  induce cell 
death, and so loss of Bid (proapop-
totic  function)  results  in  decreased 
sensitivity  (as  reported  by  Kamer, 
Sax, Jacobs, and their colleagues). 
It will  take more  research  to deter-
mine whether we are “marching”  in 
the right direction.
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Gross,  A.,  and  Korsmeyer,  S.J.  (2005).  Cell 
122, 579–591.We have recently reported (Kaufmann 
et al., 2007)  that,  in contrast  to  two 
previous  publications  (Kamer  et  al., 
2005;  Zinkel  et  al.,  2005),  the  pro-
apoptotic BH3-only protein Bid plays 
no  role  in  DNA  damage-induced 
or  replicative  stress-induced  cell-
cycle  arrest  or  apoptosis.  Here  we 
respond  to  the  concerns  about 
our  study  (Kaufmann  et  al.,  2007) 
raised  by  Zinkel  et  al.  in  their 
Correspondence.
A major  criticism by Zinkel  et  al. 
is that we did not use homogeneous 
cell  preparations or  cells  that were 
in  cycle  in  our  analyses.  First,  we 
would  like  to  point  out  that  most 
of  our  studies  with  hematopoietic 






of  their  experiments  used  primary 
splenocytes  (Supplemental  Figure 
S1A),  which  contain  at  least  seven 
different hematopoietic cell subsets. 
Although  these  authors  reported 
that  loss  of  Bid  protected  spleen 
cells from DNA damage (etoposide)-
induced  apoptosis  (Kamer  et  al., 
2005), we were unable to reproduce 
this  result  (Kaufmann  et  al.,  2007). 
Second,  our  HoxB8-immortalized 
growth  factor  (IL-3)-dependent  cell 
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implied by Zinkel et al.,  as we  rou-
tinely  select  clones  that  are  com-
parable with respect to rates of cell 
proliferation,  morphology,  and  sur-
face-marker  expression.  Zinkel  et 
al.  also  state  that  the  transformed 
mouse  embryonic  fibroblasts  we 
used  are  not  suitable  for  studying 
cellular  responses  to DNA damage 
or  replicative  stress,  asserting  that 






or  apoptosis  between  wild-type 
and  Bid-deficient  primary  mouse 
embryonic  fibroblasts  (Kaufmann 
et al., 2007). Moreover, Kamer et al. 
(2005)  reported  that  the  reduction 
in UV-  or  γ-irradiation-induced  kill-
ing of  cells  afforded by  loss of Bid 
was  even greater  (~50% difference 
between  wild-type  and  bid−/−  cells; 
Figure  1A)  in  SV40-transformed 
fibroblasts  than  in  telomerase-
immortalized fibroblasts (only ~15% 
difference;  Figure  1A).  We  found 
that  loss  of  Bid  had  no  effect  on 
progression  through  the  cell  cycle 
or  apoptosis  in  either  SV40-trans-
formed  fibroblasts  or  E1A-Ras-
transformed  fibroblasts  (Kaufmann 
et al., 2007). Given  that  the control 
of  both  apoptosis  and  passage 
through  the  cell  cycle  is  remark-
ably  conserved,  it  appears  unlikely 
that  comparatively  subtle  differ-
ences  between  cell  types  within  a 
single  species  could  explain  some 
of the opposing results reported by 




one  study  but  to  enhance  it  in  the 
other.  In  our  view,  this  is  a  funda-
mental  discrepancy  between  the 
two studies.
Zinkel et al. comment in their Cor-
respondence  that we may  not  have 
monitored  our  cohorts  of  mice  for 
a  sufficiently  long  period  to  detect 
a  role  for Bid  in  tumor suppression. 




indistinguishable  from  that  of  wild-
type mice. We agree  that  even  lon-
ger-term  followup  analyses  should 
be done to examine whether Bid can 
act as a  tumor suppressor, but cur-
rently  the evidence  for  this  is  rather 
weak.  Loss  of  the  BH3-only  pro-
teins Bim (Egle et al., 2004) or Puma 
(Hemann  et  al.,  2004)  accelerates 
lymphoma  development  in  Eµ-myc 
transgenic mice, but loss of Bid has 
no  impact  (Lindemann et  al.,  2007). 
Homozygous mutations in Bim occur 
in  certain  human  hematopoietic 
malignancies  (Tagawa  et  al.,  2005), 
but  no  such defects  in Bid  have  so 
far been found in any tumors.
In  contrast  to  both  the Kamer  et 
al.  (2005)  and  Zinkel  et  al.  (2005) 





a  widely  accepted  method  of  bio-
chemical  fractionation of cells, and 
that  we  used bid−/−  cells  to  control 
for  antibody  specificity  (Kaufmann 
et al., 2007).
Finally,  Zinkel  et  al.  claim  that  a 
new  study  (Stracker  et  al.,  2007) 
supports  their  conclusion  that  Bid 
is essential  for apoptosis  induction 
and  cell-cycle  arrest  in  response 
to  DNA  damage  via  the  ability  of 
this  stress  to  activate  ATM  kinase. 
Stracker  et  al.  generated  Nbs1∆C/∆C 
knock-in  mutant  mice  expressing 
a  truncated NBS1 protein, which  is 
unable  to  recruit  and  activate  ATM 
and therefore incapacitates the DNA 
damage  response  pathway  that 
leads to cell-cycle arrest and apop-
tosis.  Thymocytes  from  Nbs1∆C/∆C 
mutant mice,  like  thymocytes  lack-
ing ATM, are abnormally resistant to 
apoptosis  induced  by  γ-irradiation 
(Stracker et al., 2007). Puma, which 
is  transcriptionally  activated  by 
the  tumor  suppressor  p53  and  is 
the  critical  initiator  of  DNA  dam-
age-induced  apoptosis  (Jeffers  et 
al.,  2003;  Villunger  et  al.,  2003),  is 
upregulated  normally  in  Nbs1∆C/∆C 
mutant  cells,  but Bid phosphoryla-
tion is abnormally reduced in these 
cells  (Stracker  et  al.,  2007).  If  Bid 
is  the  critical  downstream  effector 





tance  to  γ-irradiation  as  ATM-defi-
cient or Nbs1∆C/∆C mutant cells. This 
seems  not  to  be  the  case  as bid−/− 
thymocytes  are  sensitive  to  this 
treatment  and  other DNA damage-




or  replicative  stress-induced  apop-
tosis or cell-cycle arrest. We believe 
that  the  existing  controversies  will 
best be resolved by other groups per-
forming similar and new experiments. 
To  facilitate  this,  we  will  be  making 
our bid−/− mice (like all of our geneti-
cally  modified  mice)  freely  available 
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